DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6vhlf3/osteonecrosis) has announced the addition of GlobalData's new report "Osteonecrosis Global Clinical Trials Review, H2, 2012" to their offering.
The clinical trial report, Osteonecrosis Global Clinical Trials Review, H2, 2012" provides data on the Osteonecrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Osteonecrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Osteonecrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Companies Mentioned:
Bone Therapeutics SA
Banc de Sang i Teixits
Amgen Inc.
Aastrom Biosciences, Inc.
Biomet, Inc.
Seoul National University Bundang Hospital
Fuzhou General Hospital
University Hospital of Liege
Fremantle Hospital and Health Service
Kyushu University
Saitama Medical University
Kaohsiung Medical University Chung-Ho Memorial Hospital
Christian Medical College
Chiba University
Osaka City University
University College London
The University of Melbourne
University hospital of North Norway
Royan Institute
University of Campinas, Brazil
Loma Linda University
University of Sao Paulo
Kyoto University
University of Michigan
University of Florida
For more information visit http://www.researchandmarkets.com/research/6vhlf3/osteonecrosis
Source: GlobalData